资讯
The initial conference welcome and introduction was hosted by Chakri Gottemukkala, o9 Solutions co-founder and CEO. Titled ...
Avidity Biosciences, Inc. ( NASDAQ: RNA) Discusses on Redefining the Treatment of Duchenne Muscular Dystrophy Conference Call September 10, 2025 8:00 AM EDT ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果